anti- MYBPC3 antibody

Este producto es parte de MYBPC - myosin binding protein C
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
anti- MYBPC3 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab05455
tested applications
ELISA, WB

Description

Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role.

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

CategoryPrimary Antibodies
Immunogen Targetmyosin binding protein C, cardiac
HostRabbit
Reactivityhuman
Recommended DilutionWB: 1:500-1:1000
Clonalitypolyclonal
ConjugationUnconjugated
IsotypeIgG
Observed MW141kd
Purity≥95% as determined by SDS-PAGE
PurificationImmunogen affinity purified
Size 1100µg
Formliquid
Tested ApplicationsELISA, WB
StoragePBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt IDQ14896
Gene ID4607
AliasFHC,CMH4,CMD1MM,LVNC10,MYBP-C,cMyBP-C,C-protein cardiac muscle isoform,Cardiac MyBP-C,Myosin-binding protein C, cardiac-type
BackgroundAntibody anti-MYBPC3
StatusRUO
NoteThis product is for research use only.

Descripción

MYBPC3 is a crucial component of the sarcomere in cardiac muscles, where it regulates cardiac contractility and stabilizes the structural framework of the thick filament. Through its interactions with myosin and actin, it modulates the force and efficiency of cardiac muscle contraction, playing a central role in maintaining the heart’s mechanical function. Mutations in MYBPC3 are a common genetic cause of hypertrophic cardiomyopathy (HCM), a condition characterized by the abnormal thickening of the heart muscle that can lead to heart failure and arrhythmias. These mutations often result in impaired sarcomere function and contribute to maladaptive cardiac remodeling. Research on MYBPC3 focuses on its role in cardiomyopathy pathogenesis and its potential as a therapeutic target for improving heart function in affected individuals.

Related Products

EH2532

Human MYBPC3(Myosin-binding protein C, cardiac-type) ELISA Kit

Ver Producto
FNab05455

anti- MYBPC3 antibody

Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role.

Ver Producto
P5804

Recombinant Human MYBPC3

Ver Producto